| MDL | MFCD00065498 |
|---|---|
| Molecular Weight | 421.02 |
| Molecular Formula | C24H37ClN2O2 |
| SMILES | CC(C)COCC(N1CCCC1)CN(C2=CC=CC=C2)CC3=CC=CC=C3.[H]Cl.[H]O[H] |
Bepridil hydrochloride hydrate ((±)-Bepridil hydrochloride hydrate) is a non-selective, long-acting Ca + channel antagonist and Na + , K + channel inhibitor, with antianginal and type I antiarrhythmic effects. Bepridil hydrochloride hydrate also acts as a cardiac Na + /Ca2 + exchange (NCX1) inhibitor. Bepridil hydrochloride hydrate can be used for the research of cardiovascular disorders [1] [2] [3] [4] [5] .
Bepridil hydrochloride hydrate blockades of Ca
2+
-dependent action potentials in vascular smooth muscle of dog coronary artery
[2]
.
Bepridil hydrochloride hydrate blocks Ca currents and Na currents with IC
50
s of 0.5 μM and 30 μM, respectively in cultured ventricular cells
[4]
.
Bepridil hydrochloride hydrate decreases I
Ks
under blockade of I
Kr
with E4031 (5 μM), in a concentration-dependent manner
[5]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Bepridil hydrochloride hydrate exhibits a half-life of averages 33±15 hours after single-dose administration
[6]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
DMSO : 125 mg/mL ( 296.90 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.3752 mL | 11.8759 mL | 23.7518 mL |
| 5 mM | 0.4750 mL | 2.3752 mL | 4.7504 mL |
| 10 mM | 0.2375 mL | 1.1876 mL | 2.3752 mL |